| P. O. Box 13967 Salem OR 97309 Phone: (503)399-0662 Fax: (503)399-0705 email: board@oregonobo.org |
State of Oregon from the Dangers of Unqualified and Improper Practice of Optometry. |
The Oregon Board of Optometry is a state agency responsible for the licensure of doctors of optometry (optometrists/optometric physicians) and enforcement of the statutes and administrative rules governing the practice of optometry in Oregon. Listed below is information concerning the Board and its activities that may be of interest to you.
   NOTICEElectronic Prescription Monitoring Program (EPMP) ~ There will be a new $25 fee included in your license renewal application for the EPMP (Electronic Prescription Monitoring Program) in the Oregon Department of Human Resources. The 2009 Legislature passed SB 355 which requires that DHS establish and maintain a prescription monitoring program for monitoring and reporting prescription drugs dispensed by pharmacies in Oregon that are classified in Scheduled II through IV under the Federal Controlled Substances Act. The EPMP will operate and be accessible by practitioners and pharmacies 24 hours a day, seven days a week. Pharmacies are required to electronically report to the EPMP information on each prescription prescribed by a practitioner. As a licensed optometric physician you will have access to the system for your use in providing eye care to your patients. The Oregon Board of Optometry has no responsibility for this prescription monitoring system. We are required by the provisions of SB 355 to collect a $25 fee on all license renewals and send the money to the EPMP for their use in setting up and maintaining this system. This will be an annual renewal fee that will be collected with each year’s license renewal beginning January 2010. Please contact the Board’s office if you would like further information on this matter. |
| LATISSE ~ Latisse was approved by the Oregon Board of Optometry, at its meeting on March 13, 2009, as being a pharmaceutical agent on the topical formulary for Oregon optometric physicians. The use of Latisse for hypotrichosis was approved as being within the scope of practice for optometric physicians in Oregon. Latisse can be prescribed by optometric physicians and can be sold to their patients providing all of the labeling and dispensing requirements have been met. Prescription drugs cannot be dispensed by an optometeic physician to anyone other than a patient with whom he or she has a bonafide physician/patient relationship. |
| BOARD MEMBERS SOUGHT Members of the Oregon Board of Optometry are appointed by and serve at the pleasure of the Governor. The term of office of each member is three years. A member is eligible for reappointment. Candidates for member positions are currently being sought. If you have an interest in serving on the Oregon Board of Optometry please complete the Executive Appointment Interest Form or contact the Board's office. In selecting the members of the Board, the Governor shall strive to balance representaton on the Board according to geographic areas of this state and by ethnic group. |
Related Links:
   |
|
PUCO (Pacific University College of Optometry - Online Continuing Education) |
OOPA (Oregon Optometric Physicians Association |
|
AOA (American Optometric Association) Home Page |
ARBO (Association of Boards of Optometry) Home Page |
|
COPE (Council on Optometric Practitioner Education) Home Page |
NBEO (National Board of Examiners in Optometry) Home Page |
NPDB-HIPDB (National Practitioner Data Bank and Healthcare Integrity and Protection Data Bank) Physicians can perform a "self query" at this site. |
FEDERAL TRADE COMMISSION - "The Contact Lens Rule: A Guide for Prescribers and Sellers." |
U.S. FOOD AND DRUG ADMINISTRATION - Mandatory Reporting Form   Report violations of dispensing products which require a prescription - such as contact lenses - at this site.) |
BME (Oregon Board of Medical Examiners) |
DEA (United States Drug Enforcement Administration/Practitioner Registration) |
Oregon Requirements For Tinting of Windshields   ORS 815.221 and 815.222 explaining the statutory requirements for prescribing the tinting of automotive windshields. |
Oregon DMV's Medically At-Risk Driver Program |
Please send suggestions to:
David Plunkett, Executive Director
This page was last revised: FEBRUARY 8, 2010
Disclaimer - This web site contains links to other web sites for your convenience. When you use these links, you are no longer on this site and this Privacy Notice will not apply. When you link to another web site, you are subject to the privacy policy of that new site. When you follow a link to one of these sites neither the State of Oregon, nor any agency, officer, or employee of the State of Oregon warrants the accuracy, reliability or timeliness of any information published by these external sites, nor endorses any content, viewpoints, products, or services linked from these systems, and cannot be held liable for any losses caused by reliance on the accuracy, reliability or timeliness of their information.